Blog
Sweat for NETRF
On February 29th, employees and friends of eGlobalTech participated in a BodyPump exercise class led by Lauren Maxwell at VIDA Logan Circle to raise funds
March 12, 2020
No Comments
Category: Blog
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
Milestone Achievements Announced in NET Cell Line Development
NETRF reports progress in the development of neuroendocrine tumor cell lines to help eliminate a decades-old obstacle in laboratory research. To stimulate progress in NET cell lines, NETRF established a Cell Line Prize, funded cell line research, and launched a collaboration with a nationally known research institute. Each of these initiatives has succeeded in establishing NET cell lines.
March 11, 2020
No Comments
Blog
NETRF Welcomes New Members to its Board of Scientific Advisors
NETRF welcomes five new members to its Board of Scientific Advisors, a volunteer council of highly distinguished medical and research leaders who share NETRF’s commitment to advancing the diagnosis and treatment of neuroendocrine cancer.
March 11, 2020
No Comments
Blog
It’s Our 15th Anniversary
In March of 2005, the Caring for Carcinoid Foundation was recognized as a non-profit, 501(c)3 foundation, established by a visionary group led by patient Nancy
March 10, 2020
No Comments
Blog
Thank you for supporting NET research in 2019
Thank you for supporting NET research in 2019 Together we can fund research needed to find a cure for neuroendocrine cancer The 2019 results are
February 10, 2020
No Comments
Blog
NETRF Awards $3.5 Million in Grants
Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF) today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12
February 10, 2020
1 Comment
Blog
Exploring new ground with a clinical trial of a NET cancer vaccine
A NETRF-funded clinical trial looks at a cancer vaccine called SurVaxM in neuroendocrine cancer to help slow or stop the spread of neuroendocrine tumors.
January 23, 2020
No Comments
Blog
Celebrating the Next Chapter
After chemotherapy for pancreatic NET, Chef Jack Riebel embraces life with new optimism, doing what he enjoys most, and finding meaning by giving back.
January 9, 2020
No Comments
Blog
Spirituality and Cancer
Many people with neuroendocrine cancer look more deeply for meaning in their lives. They want to understand their purpose in life or why they got cancer.
December 19, 2019
1 Comment
Blog
COMPETE Clinical Trial
A new phase III clinical trial called COMPETE (NCT03049189 ) compares everolimus, an oral targeted therapy, to PRRT with Lu-177 edotreotide, a radiopharmaceutical under development,
November 18, 2019
No Comments